ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung - Cancer

January 11, 2019
Patient Care and General Interest Ireland’s Cabinet is expected to consider opt-out organ donation legislation this spring.
January 10, 2019
Filmed at the 2018 STS Annual Meeting in Fort Lauderdale, Florida, Douglas Wood of the University of Washington in Seattle moderates a debate on the criteria that should be used to select which patients should undergo lung cancer screening.
January 9, 2019
Within a year after a diagnosis of lung cancer the suicide rate for such patients is 6 times higher than in the general population. This is among the greatest increases in the risk of suicide among all cancer diagnoses.
November 15, 2018
Paul Van Schil of Antwerp University Hospital in Belgium discusses surgical approaches for various stages of non-small cell lung cancer.
November 9, 2018
A multidisciplinary team led by Bob Kiaii at the London Health Sciences Centre in Ontario, Canada, has reportedly completed the world's first robotic performance of a specific aortic valve replacement procedure in a patient with aorti
October 31, 2018
The authors present a video of a robotic assisted pulmonary segmentectomy of the anterior segment of the right upper lobe (S3) for a metastatic nodule.
October 24, 2018
This video demonstrates the surgical treatment of a 71-year-old patient with multifocal lung cancer who initially underwent a left VATS upper lobectomy, followed by a robotic completion pneumonectomy.
October 23, 2018
In a single institution review comparing acute outcomes for men and women after surgery for non-small cell lung cancer, men were found to have an increased risk of postoperative cardiac complications, whereas women were found to have an increased incidence of 30-day readmission, the latter despite similar frequency of postoperative emergency departme
October 23, 2018
Forty-nine patients with limited metastatic non-small cell lung cancer (three or fewer metastatic sites) who did not progress on initial systemic therapy were randomized to surgery or RT vs standard maintenance therapy.  Overall survival for the intervention group was 41.2 mos vs 17.0 mos in those getting maintenance therapy (p=0.017). 

Pages